|
|
European Frameworks for Vaccination Policy
European Vaccine Evaluation and Authorisation
An Evolving Role for Big Pharma
Vaccine Corporate Growth Strategies
Biotech Start-Up Innovation Showcases
Vaccine Introduction Review
European Influenza Preparedness
The Flu Paradox
The Future Direction of Vaccine R&D
Vaccine Clinical Development Complexities
Manufacture, Process Development and Scale-Up
Cell Culture Based Production – The Next Frontier?
Streamlining Vaccine Adjuvant R&D
Intra-Market Regulatory Challenges
Vaccine Safety Evaluation
Confronting Economic Funding Challenges
Sourcing and Securing Private Funding
Driving and Maintaining Funding Momentum
› download conference brochure
› add this to my calendar
|
|
|
|
| |
|
The World Vaccine Congress Lyon is the annual vaccine conference addressing every aspect of vaccine research, vaccine development and vaccine manufacturing.
Exclusive vaccine R&D updates on:
|
|
|
The World Vaccine Congress Lyon is where pharmaceutical companies, biotechs, healthcare firms and investors to discuss future strategy and opportunity within the industry.
Vaccine Industry Survey Results
More than 250 vaccine industry-side respondents offered up their opinions on vaccine industry trends for the 2009 poll.
1-2-1 partnering
Opportunities with "Contact" - Schedule dedicated onsite meetings with partners and gain the visibility your company needs.
“Very well organized and great networking opportunities”
Visti Wedege, Business Manager, NUNC A/S
Biotech discounts
To ensure a balance of participant at the Congress we have organised some fantastic discounts for small / early stage biotechs. These exclusive prices can only be secured by contacting the Congress Director Neil Darkes directly.
meet new partners
Key reasons to attend
Representation from key European Commission and regulatory agencies
DG Research, DG SANCO, ECDC, EDQM, CHMP, VWP, MHRA, PEI, FAMHP and MEB provide vision and clarity on future industry progress and opportunities
Europe’s largest commercial vaccine industry congress for decision makers across European and North America regions
Including World class multiple speaker representation from Baxter, GSK Biologicals, MedImmune, Novartis Vaccines and Diagnostics, Pfizer, sanofi pasteur, sanofi Pasteur MSD, Solvay and Wyeth Vaccines
Critical market opportunities outlined in billion Euro vaccine market
European policy frameworks, vaccine regulation and authorisation, vaccine R&D innovation and introduction, Influenza market sustainability, corporate growth strategies and funding sources
|
 |
|
|
|
| |
DR OLE OLESEN
Scientific Officer, Neglected Infectious Diseases, Infectious Diseases Unit, DG-Research
European Commission
|
|
DR PIERLUIGI LOPALCO
Senior Expert, Scientific Advice Unit
European Centre for Disease Prevention and Control
DR ALLAN JARVIS
Senior Vice President, Corporate Development
sanofi pasteur
DR JOE COHEN
Vice President R&D, Head of Vaccines for Emerging Diseases and HIV
GSK Biologicals
DR JEFFREY ULMER
Global Head of External Research
Novartis Vaccines and Diagnostics
|
|
DIDIER HOCH
President
sanofi pasteur MSD
and Former President
European Vaccine Manufacturers
DR PETER DULL
Head of Department, Meningococcal Conjugate Vaccines
Novartis Vaccines & Diagnostics
|
|
|
| |
|
Benefit from an outstanding marketing campaign!
Before, during and after the event!
World Vaccine Congress Lyon 2009 is more than just an event – it is an opportunity to take an important place in a regional, targeted, 24/7 marketing campaign. The earlier you confirm your participation, the more marketing benefits and the greater ROI you will receive.
Our sponsors enjoy unparalleled market exposure that culminates in face-to-face meetings with existing customers and new business prospects. We undertake a comprehensive global marketing campaign reaching the highest echelons within your targeted markets.
» find out about sponsorship
» looking for an event taking place sooner or in a different part of the world?
|
|
|
|
|
